Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model

Spine

Volumn 34, Issue 3, 2009, Pages 249-254

  Sasaki, Hirofumi ^a   Ishikawa, Masakazu ^a   Tanaka, Nobuhiro ^a   Nakanishi, Kazuyoshi ^a   Kamei, Naosuke ^a   Asahara, Takayuki ^b   Ochi, Mitsuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD133; Cell therapy; Spinal cord injury; Vascular endothelial growth factor; Vasculogenesis

Indexed keywords

PHOSPHATE BUFFERED SALINE; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD33+ CELL; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; FEASIBILITY STUDY; GLIOSIS; HISTOPATHOLOGY; IN VIVO STUDY; MALE; NERVE FIBER REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODEL; ENDOTHELIUM CELL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; NERVE REGENERATION; NUDE RAT; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GLYCOPROTEINS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE REGENERATION; NEUROGENESIS; PEPTIDES; RATS; RATS, NUDE; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64849100810     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181913cde     Document Type: Article

References (25)

1. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med 1999;5:1410-2.
2. Chopp M, Zhang XH, Li Y, et al. spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000;11:3001-5.
3. Ogawa Y, Sawamoto K, Miyata T, et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 2002;69:925-33.
4. Takami T, Oudega M, Bates ML, et al. Schwann cell but not olfactory ensheathing glia transplants improve hind-limb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci 2002;15: 6670-81.
5. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
6. Kawamoto A, Asahara T, Losordo DW, et al. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 2002;3:221-5.
7. Suh W, Kim KL, Kim JM, et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005;23:1571-8.
8. Ueno T, Nakamura T, Torimura T, et al. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 2006;39:16-21.
9. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34( + ) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hema-topoiesis in an autocrine/paracrine manner. Blood 2001;97:3075-85.
10. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60.
11. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 2004;187:246-53.
12. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12.
13. Goussetis E,TheodosakiM,Paterakis G,et al. Afunctional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differen-tiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells. J Hematother Stem Cell Res 2000;9:827-40.
14. Tondreau T, Meuleman N, Delforqe A, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005;23: 1105-12.
15. Fujiwara Y, Tanaka N, Ishida O, et al. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes, and oligodendrocytes. Neurosci Let 2004; 366:287-91.
16. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12:1-21.
17. Fehlings MG, Tator CH, Linden RD. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol 1989;74:241-59.
18. Balentine JD. Pathology of experimental spinal cord trauma: the necrotic lesion as a function of vascular injury. Lab Invest 1978;39:236-53.
19. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991;37:291-302.
20. Iwasaki H, Kawamoto A, Ishikawa M, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and car-diomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006;113:1311-25.
21. Matsumoto T, Kawamoto A, Kuroda R, et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 2006;169:1440-57.
22. Widenfalk J, Lipson A, Jubran M, et al. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 2003;120:951-60.
23. Stumm RK, Zhou C, Ara T, et al. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 2003;23:5123-30.
24. Peng H, Huang Y, Rose J, et al. Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J Neurosci Res 2004;76:35-50.
25. Kucia M, Wojakowski W, Reca R, et al. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch Immunol Ther Exp 2006; 54:121-35.